Please login to the form below

Not currently logged in
Email:
Password:

The LionsDen Communications Award for Excellence in Payer and Policy Maker Engagement


The LionsDen Communications Award for Excellence in Payer and Policy Maker Engagement

This award recognises excellence in programmes that engage one or more key payer/stakeholder group(s) (national, regional or European) to develop and broaden debate with clinical, governmental, public and/or other stakeholders to achieve policy change that will lead to improvements in:

  • Health outcomes - delivered by challenging inequality of health outcomes, clinical care or access to medicines or services
  • Clinical practice 
  • Standards of treatment
  • Planning, coordination or delivery of services. 

Work carried out during the two-year period between January 2011 and December 2012 will be eligible.

Submissions entered previously must demonstrate how the programme has been further developed during the additional time period.

Entries are invited from:

  • Charities
  • Patient or professional associations/bodies
  • Pharmaceutical companies
  • Healthcare agencies/consultancies
  • Trade associations.

Judging criteria:

  • Analysis of the problem and evidence of customer insight
  • Quality of the strategy/tactics employed to achieve key objectives
  • Evidence of change effected through communication with national or European payers/policy makers 
  • Evidence of support from a range of interested stakeholders, e.g. healthcare professionals and patient representatives
  • Effectiveness - evidence of changed behaviours and enhanced health outcomes
  • Stakeholder/customer feedback


Sponsors

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics